Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus

NCT01821846 · Completed

Last updated 2026-05-28

This clinical trial is studying the safety of the medication liraglutide in Korean adults with type 2 diabetes under normal use conditions.

Status Completed The study has finished.

Type Observational

Participants 64 people

Who can join all sexes

Timeline Started 2013-11 · est. completion 2017-03

Where 7 sites · South Korea

What this study is testing ClinicalTrials.gov NCT01821846 ↗

Description as written by the study sponsor.

This trial is conducted in Asia. The aim of this study is to investigate the safety profile of liraglutide (Victoza®) under normal conditions of use in Korean subjects with type 2 diabetes mellitus.

Treatments tested

liraglutide Drug

Administered either alone or in combination therapy according to the package insert (PI). Self-administered once daily, at any time subcutaneously (s.c., under the skin) in the abdomen, thigh or upper arm).

Main thing measured	The incidence of SADRs (Serious Adverse Drug Reactions)
Sponsor	Novo Nordisk A/S
Conditions studied	Diabetes, Diabetes Mellitus, Type 2
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT01821846 ↗